Table 2.
Levels of Matrix Metalloproteinase-1 (MMP-1), Matrix Metalloproteinase-9 (MMP-9), Tissue Inhibitor of Matrix Metalloproteinase-1 (TIMP-1) and Interleukin-6 (IL-6) in Different Clinical Groups
| Marker | Clinic | N | Mean | Minimum | Maximum |
|---|---|---|---|---|---|
| MMP-1 (ng/ml) | control | 30 | 0.989 | 0.10 | 4.08 |
| STEMI | 25 | 5.8232 | 0.08 | 13.60 | |
| NSTEMI | 16 | 4.6969 | 0.21 | 9.89 | |
| USAP | 29 | 2.3224 | 0.28 | 11.87 | |
| SAP | 34 | 2.8668 | 0.11 | 14.73 | |
| Total | 134 | 3.0987 | 0.08 | 14.73 | |
| MMP-9 | control | 30 | 175.16 | 52.0 | 431.0 |
| (ng/ml) | STEMI | 25 | 454.36 | 58.0 | 1500.0 |
| NSTEMI | 16 | 284.43 | 52.0 | 1008.0 | |
| USAP | 29 | 209.93 | 31.0 | 537.0 | |
| SAP | 34 | 291.67 | 52.0 | 1261.0 | |
| Total | 134 | 277.38 | 31.0 | 1500.0 | |
| IL-6 | control | 30 | 1.81 | 1.55 | 2.88 |
| (pg/ml) | STEMI | 25 | 2.74 | 1.55 | 6.06 |
| NSTEMI | 16 | 2.96 | 1.64 | 6.93 | |
| USAP | 29 | 2.19 | 1.55 | 6.86 | |
| SAP | 34 | 2.13 | 1.55 | 7.01 | |
| Total | 134 | 2.28 | 1.55 | 7.01 | |
| TIMP-1 | control | 30 | 527.79 | 177.20 | 953.00 |
| (ng/ml) | STEMI | 25 | 466.68 | 65.20 | 768.50 |
| NSTEMI | 16 | 478.88 | 44.0 | 720.70 | |
| USAP | 29 | 516.69 | 110.5 | 1212.80 | |
| SAP | 34 | 551.69 | 111.10 | 1280.00 | |
| Total | 134 | 514.21 | 44.0 | 1280.00 | |